Drug Trial Radar · NCT05526391
A Study of TAK-341 in Treatment of Multiple System Atrophy
Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
158
Actual
Start
Nov 16, 2022
Primary completion
Jul 28, 2025
Study completion Jul 28, 2025
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Sep 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS). The study will enroll approximately 138 patients. Participants will receive a total of 13 intravenous infusions every 4 weeks approximately, these may be either of TAK-341 or placebo, after each infusion some blood samplings will be taken and other assessments completed. This trial will be conducted in North America, Europe and Asia.
Conditions
- Multiple System Atrophy
Interventions
PlaceboDrug
TAK-341-matching placebo IV infusion
TAK-341Drug
TAK-341 IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Modified Unified Multiple System Atrophy Rating Scale (UMSARS) Part I Total Score at Week 52Time frame: Baseline, Week 52
Locations
41 sites in 10 countries. Site status is shown where the registry gives one.
Quest Research Institute - Alcanza - HyperCore
Farmington Hills, Michigan
Mayo Clinic
Rochester, Minnesota
NYU Langone Health
New York, New York
Duke University School of Medicine
Durham, North Carolina
The Cleveland Clinic Foundation
Cleveland, Ohio
University of Texas Southwestern Medical Center
Dallas, Texas
Inland Northwest Research
Spokane, Washington
Medizinische Universitat Graz
Graz, Styria, Austria
Aarhus Universitetshospital
Aarhus N, Denmark
Bispebjerg Hospital
København NV, Capital, Denmark
Hopitaux de La Timone
Marseille, Bouches-du-Rhone, France
Charite - Universitatsmedizin Berlin
Berlin, Germany
Klinikum Groshadern, LMU
München, Bavaria, Germany
Paracelsus-Elena-Klinik Kassel
Kassel, Hesse, Germany
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
Universitaetsklinikum der Ruhr-Universitaet Bochum (UKRUB) - St. Josef-Hospital
Bochum, North Rhine-Westphalia, Germany
Deutsches Zentrum fur Neurodegenerative Erkrankung
Bonn, North Rhine-Westphalia, Germany
Universitatsklinikum Munster
Münster, North Rhine-Westphalia, Germany
Universitatsklinikum Carl Gustav Carus an der TU Dresden
Dresden, Saxony, Germany
Universitatsklinikum Leipzig
Leipzig, Saxony, Germany
Azienda Ospedaliera Universitaria OO.RR. San Giovanni di Dio Ruggi dAragona
Salerno, Italy
IRCCS San Raffaele Roma
Rome, Lazio, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, Lombardy, Italy
Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta
Milan, Lombardy, Italy
Istituto Clinico Humanitas
Rozzano, Lombardy, Italy
Azienda Ospedale Universita Padova
Padova, Veneto, Italy
Chiba University Hospital
Chuo-ku, Chiba, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Kyoto University Hospital
Kyoto, Kyoto, Japan
The University of Tokyo Hospital
Bunkyo-Ku, Tokyo, Japan
Medical Hospital of Tokyo Medical and Dental University
Bunkyo-Ku, Tokyo, Japan
National Center of Neurology and Psychiatry
Kodaira-Shi, Tokyo, Japan
Campus Neurologico Senior
Loures, Lisbon District, Portugal
Hospital Pedro Hispano
Senhora da Hora, Porto District, Portugal
Hospital Universitario Vall d'Hebron
Barcelona, Spain
Hospital de La Santa Creu i Sant Pau
Barcelona, Spain
Hospital Universitario de La Princesa
Madrid, Spain
Hospital Universitario Ramon y Cajal
Madrid, Spain
Hospital Universitari i Politecnic La Fe de Valencia
Valencia, Spain
Hospital Universitario Cruces
Barakaldo, Vizcaya, Spain
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.